首页> 美国卫生研究院文献>other >Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study
【2h】

Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study

机译:多变量分析作为变应性支气管肺曲霉病诊断流程图的支持:概念验证研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Molecular-based allergy diagnosis yields multiple biomarker datasets. The classical diagnostic score for allergic bronchopulmonary aspergillosis (ABPA), a severe disease usually occurring in asthmatic patients and people with cystic fibrosis, comprises succinct immunological criteria formulated in 1977: total IgE, anti-Aspergillus fumigatus (Af) IgE, anti-Af “precipitins,” and anti-Af IgG. Progress achieved over the last four decades led to multiple IgE and IgG(4) Af biomarkers available with quantitative, standardized, molecular-level reports. These newly available biomarkers have not been included in the current diagnostic criteria, either individually or in algorithms, despite persistent underdiagnosis of ABPA. Large numbers of individual biomarkers may hinder their use in clinical practice. Conversely, multivariate analysis using new tools may bring about a better chance of less diagnostic mistakes. We report here a proof-of-concept work consisting of a three-step multivariate analysis of Af IgE, IgG, and IgG4 biomarkers through a combination of principal component analysis, hierarchical ascendant classification, and classification and regression tree multivariate analysis. The resulting diagnostic algorithms might show the way for novel criteria and improved diagnostic efficiency in Af-sensitized patients at risk for ABPA.
机译:基于分子的过敏诊断产生了多个生物标志物数据集。过敏性支气管肺曲霉菌病(ABPA)是一种常见于哮喘患者和囊性纤维化患者的严重疾病,其经典诊断评分包括1977年制定的简洁免疫学标准:总IgE,抗烟曲霉(Af)IgE,抗Af“沉淀蛋白”和抗Af IgG。在过去的四十年中取得的进展导致产生了多个IgE和IgG(4)Af生物标记物,这些标记物具有定量,标准化的分子水平报告。尽管ABPA持续诊断不足,但这些新获得的生物标记物尚未单独或包括在当前的诊断标准中。大量的单个生物标志物可能会阻碍其在临床实践中的使用。相反,使用新工具进行的多变量分析可能会带来更少的诊断错误。我们在此报告概念验证工作,该工作由三步多变量分析Af IgE,IgG和IgG4生物标记组成,方法是结合主成分分析,分级上升分类以及分类和回归树多变量分析。最终的诊断算法可能为在ABPA风险中对Af敏感的患者提供新的标准和提高诊断效率的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号